There are almost 900 drugs in the adult cancer pipeline, but only a handful are in development for children. The Pediatric Research Equity Act (PREA) addresses this problem by requiring drug companies to develop their adult drugs in children as well. However, PREA has never applied to cancer drugs because children’s cancers occur in different organs than adult cancers. The RACE for Children Act (Research to Accelerate Cures and Equity Act) would update PREA by providing that companies developing a cancer drugs would undertake PREA studies of their drug in children when the molecular target of their drug is relevant to a children’s cancer. To find out more about the RACE for Children Act, please click here.
The need: The RACE Act is in the final sprint. We must ask Congress to attach the RACE Act to the PDUFA Act some time before Congress passes PDUFA in June 2017.